Cortisol is the body’s primary stress hormone, and testing for it no longer has to mean a needle. Alongside the traditional blood draw at a clinic, labs and startups now measure it in saliva, in some cases at home. Saliva-based testing is identified as one of the fastest-expanding segments of the cortisol testing market.
Background
Cortisol is produced by the adrenal glands and regulates metabolism, immune response and sleep cycles, among other things. Its level is highest in the early morning and lowest at midnight. Testing is used for adrenal dysfunction diseases such as Cushing syndrome (excessive cortisol) and Addison’s disease (insufficient cortisol), and in research on sleep disorders, stress physiology and mental health.
The traditional test measures total cortisol, which includes hormone bound to proteins as well as “free” hormone. It needs venipuncture, a needle draw at a clinic or lab, and usually gives a single morning snapshot at 8:00 AM. Stress bias is high, because the “white coat effect” or needle phobia can spike results. It is the gold standard for diagnosing diseases, and it is inexpensive and usually covered by insurance.
The salivary test measures free cortisol, the active hormone available to tissues. Collection means spitting into a tube, which can be done at home, and multiple samples throughout the day capture the diurnal rhythm. Stress bias is low because the test is done in a familiar, relaxed environment. It is excellent for assessing HPA-axis dysfunction (burnout and stress), though it is often paid out of pocket and multi-sample kits cost more.
The technology
About 90% of the cortisol in the body is bound to proteins like corticosteroid-binding globulin (CBG) and albumin. That portion is inactive and is only being transported. The remaining 10% is active cortisol, whose molecules pass easily through the lipid membranes of the gland cells and into the saliva. This is what a salivary test measures. The challenge is that cortisone in saliva interferes with cortisol detection.
Once a sample is obtained, biochemical assays detect the cortisol level. ELISA (enzyme-linked immunosorbent assay) is the most common method. The lab uses antibodies designed to “grab” cortisol molecules, and a color-changing enzyme signals how much cortisol is present. LC-MS/MS (liquid chromatography-tandem mass spectrometry) is the gold standard for high precision. It separates the chemicals in the saliva and identifies them by their specific molecular weight and “fingerprint”, ensuring that no other steroids, like cortisone, are accidentally counted.
ELISA is what labs use. Consumer tests such as Eli Health’s use lateral flow strips, in the style of a pregnancy test, and clinical startups such as ReMinded Inc use a biosensor reader that takes an electronic measurement.
The market
The global cortisol testing market reached $2.1 billion in 2024 and is projected to hit $4.3 billion by 2033, a CAGR (mean annual growth rate) of 8.4%. Saliva-based testing is growing fast because it is non-invasive and because diagnostics are shifting toward the home.
ReMinded Inc is building a clinical point-of-care diagnostic that pairs a saliva strip with a dedicated reader device. It returns results in minutes (the exact time is not public), targets hospitals and mental health clinics, and is at the prototype stage, preparing for FDA clearance.
Eli Health offers consumer hormone tracking, with a saliva strip read by phone camera AI in about 20 minutes. Its customers are consumers, biohackers and the wellness market, and the product is an FDA-registered wellness device, not a diagnostic.
ZRT Laboratory, Ayumetrix and Genova Diagnostics offer lab-based hormone testing. Their multi-timepoint saliva cortisol tests are commercial lab tests for functional medicine doctors, patients and physicians, with results in 7+ days.
What comes next
One market opportunity is point-of-care (POC) testing, where there is huge potential for rapid test kits in primary care and corporate wellness programs. Another is preventative health, with testing integrated into routine wellness check-ups rather than used only for disease diagnosis. Biohacking and everyday monitoring is a third.
Salivary hormone testing is also moving from single tests toward continuous monitoring. Researchers are developing technologies that allow continuous or repeated hormone monitoring, and they are exploring multiplex sensors that measure cortisol, testosterone, estrogen and other hormones. Multi-hormone testing could expand applications in areas such as reproductive health and endocrine disorders.
A Growth Market Reports forecast for 2019 to 2034 shows the global market growing each year, segmented by product type (ELISA kits, immunoassay analyzers, rapid test kits), sample type (blood, saliva, urine, hair), end user (hospitals and clinics, diagnostic laboratories, research institutes) and distribution channel (direct sales, online retail).